Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin plus Paclitaxel in Advanced Thymoma or Thymic Carcinoma
NCT00010257Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jun 2001
- Primary completion
- Nov 2008
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin and Paclitaxel Micelles for Injection in thymoma and thymic carcinoma (TC), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Objective Response Rate. Started Jun 2001; status: completed.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT00010257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010257.